Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
inactivated SARS-CoV-2 vaccine (Vero cell) (Sinovac Life Sciences)
- Development stage
- Unknown
- Lead developer
- Sinovac Biotech
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The inactivated SARS-CoV-2 vaccine (Vero cell) is a vaccine developed to prevent COVID-19. It is produced by cultivating SARS-CoV-2 virus strains in Vero cells, followed by inactivation with chemicals such as β-propiolactone or formaldehyde to destroy the viral membrane and genomic structure while preserving antigenic properties. The inactivated virus is then purified, concentrated, and typically adsorbed to aluminum hydroxide as an adjuvant. This vaccine works by introducing the inactivated virus to stimulate the immune system to produce neutralizing antibodies against SARS-CoV-2 without causing infection. Clinical trials have shown the vaccine can induce seroconversion and provide protection against COVID-19.
- Brand names
- CoronaVacVaksin Merah Putih - UA SARS-CoV-2
- Other names
- COVID-19 Vaccine (Vero Cell), InactivatedSARS-CoV-2 Vaccine (Vero Cell), InactivatedCoronaVac
02
Targets
SARS-CoV-2 spikeN (Nucleocapsid protein)
Beyond the preview
Go deeper on inactivated SARS-CoV-2 vaccine (Vero cell) (Sinovac Life Sciences).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on inactivated SARS-CoV-2 vaccine (Vero cell) (Sinovac Life Sciences).